CBX7 is Dualistic in Cancer Progression Based on its Function and Molecular Interactions

Area of Science:

• Molecular Biology
• Epigenetics
• Cancer Biology

Background:

• Chromobox protein homolog 7 (CBX7) is part of the Polycomb Repressive Complex 1 (PRC1).
• CBX7 functions as an epigenetic regulator controlling gene expression.
• Aberrant CBX7 expression is linked to cancer development and progression.

Purpose of the Study:

• To investigate the multifaceted role of CBX7 in cancer.
• To explore CBX7's interactions with genes, proteins, and RNAs in cancer.
• To understand CBX7's involvement in cancer-related pathways, immunity, and DNA repair.

Main Methods:

• Literature review on CBX7's function in various cancers.
• Analysis of CBX7's interactions with oncosuppressor genes and cell cycle proteins.
• Examination of CBX7's interplay with microRNAs, long noncoding RNAs, and circular RNAs.
• Review of CBX7's role in cancer immunity and DNA repair mechanisms.

Main Results:

• CBX7 exhibits a dual role in cancer, inhibiting tumor suppressors in some cases and suppressing tumors in others.
• CBX7 interacts with diverse molecules, including various RNA types, influencing cancer pathways.
• CBX7 is implicated in cancer-associated immune responses and DNA repair processes.

Conclusions:

• CBX7's expression is a critical determinant in cancer initiation and advancement.
• Understanding CBX7's complex roles offers potential therapeutic targets in oncology.
• CBX7's epigenetic regulatory functions are central to its impact on cancer biology.